{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:39:16Z","timestamp":1778877556880,"version":"3.51.4"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,7,17]],"date-time":"2008-07-17T00:00:00Z","timestamp":1216252800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s10038-008-0316-9","type":"journal-article","created":{"date-parts":[[2008,7,16]],"date-time":"2008-07-16T05:59:25Z","timestamp":1216187965000},"page":"812-824","source":"Crossref","is-referenced-by-count":31,"title":["Structural characterization of mutant \u03b1-galactosidases causing Fabry disease"],"prefix":"10.1038","volume":"53","author":[{"given":"Kanako","family":"Sugawara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,17]]},"reference":[{"key":"316_CR1","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s100380170088","volume":"46","author":"GA Ashley","year":"2001","unstructured":"Ashley GA, Shabbeer J, Yasuda M, Eng CM, Desnick RJ (2001) Fabry disease: twenty novel alpha-galactosidase A mutations causing the classical phenotype. J Hum Genet 46:192\u2013196","journal-title":"J Hum Genet"},{"key":"316_CR2","first-page":"227","volume":"48","author":"P Ashton-Prolla","year":"2000","unstructured":"Ashton-Prolla P, Tong B, Shabbeer J, Astrin KH, Eng CM, Desnick RJ (2000) Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype\/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes. J Investig Med 48:227\u2013235","journal-title":"J Investig Med"},{"key":"316_CR3","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1172\/JCI114027","volume":"83","author":"HS Bernstein","year":"1989","unstructured":"Bernstein HS, Bishop DF, Astrin KH, Kornreich R, Eng CM, Sakuraba H, Desnick RJ (1989) Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene. J Clin Invest 83:1390\u20131399","journal-title":"J Clin Invest"},{"key":"316_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/(SICI)1098-1004(1996)8:1<38::AID-HUMU5>3.0.CO;2-L","volume":"8","author":"LC Blanch","year":"1996","unstructured":"Blanch LC, Meaney C, Morris CP (1996) A sensitive mutation screening strategy for Fabry disease: detection of nine mutations in the alpha-galactosidase A gene. Hum Mutat 8:38\u201343","journal-title":"Hum Mutat"},{"key":"316_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/humu.1219","volume":"18","author":"D Blaydon","year":"2001","unstructured":"Blaydon D, Hill J, Winchester B (2001) Fabry disease: 20 novel GLA mutations in 35 families. Hum Mutat 18:459","journal-title":"Hum Mutat"},{"key":"316_CR6","first-page":"347","volume":"115","author":"J Calado","year":"2004","unstructured":"Calado J, Dickson J, Rueff J (2004) Human gene mutations. Hum Genet 115:347","journal-title":"Hum Genet"},{"key":"316_CR7","first-page":"535","volume":"107","author":"A Cooper","year":"2000","unstructured":"Cooper A, Cooper JA, Wraith JE (2000) Human gene mutations. Hum Genet 107:535\u2013536","journal-title":"Hum Genet"},{"key":"316_CR8","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/hmg\/2.7.1051","volume":"2","author":"JP Davies","year":"1993","unstructured":"Davies JP, Winchester BG, Malcolm S (1993) Mutation analysis in patients with the typical form of Anderson-Fabry disease. Hum Mol Genet 2:1051\u20131053","journal-title":"Hum Mol Genet"},{"key":"316_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/hmg\/3.4.667","volume":"3","author":"J Davies","year":"1994","unstructured":"Davies J, Christomanou H, Winchester B, Malcolm S (1994) Detection of 8 new mutations in the alpha-galactosidase A gene in Fabry disease. Hum Mol Genet 3:667\u2013669","journal-title":"Hum Mol Genet"},{"key":"316_CR10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000472202","volume":"4","author":"JP Davies","year":"1996","unstructured":"Davies JP, Eng CM, Hill JA, Malcolm S, MacDermot K, Winchester B, Desnick RJ (1996) Fabry disease: fourteen alpha-galactosidase A mutations in unrelated families from the United Kingdom and other European countries. Eur J Hum Genet 4:219\u2013224","journal-title":"Eur J Hum Genet"},{"key":"316_CR11","first-page":"3733","volume-title":"The metabolic and molecular bases of inherited disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng CM (2001) Alpha-galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3733\u20133774","edition":"8"},{"key":"316_CR12","first-page":"647","volume":"83","author":"R Dobrovolny","year":"2005","unstructured":"Dobrovolny R, Dvorakova L, Ledvinova J, Magage S, Bultas J, Lubanda JC, Elleder M, Karetova D, Pavlikova M, Hrebicek M (2005) Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population. J Mol Med 83:647\u2013654","journal-title":"Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population. J Mol Med"},{"key":"316_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/jcc.540160702","volume":"16","author":"MJ Dudek","year":"1995","unstructured":"Dudek MJ, Ponder JW (1995) Accurate modeling of the intramolecular electrostatic energy of proteins. J Comput Chem 16:791\u2013816","journal-title":"J Comput Chem"},{"key":"316_CR14","first-page":"1186","volume":"53","author":"CM Eng","year":"1993","unstructured":"Eng CM, Resnick-Silverman LA, Niehaus DJ, Astrin KH, Desnick RJ (1993) Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease. Am J Hum Genet 53:1186\u20131197","journal-title":"Am J Hum Genet"},{"key":"316_CR15","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/hmg\/3.10.1795","volume":"3","author":"CM Eng","year":"1994","unstructured":"Eng CM, Niehaus DJ, Enriquez AL, Burgert TS, Ludman MD, Desnick RJ (1994) Fabry disease: twenty-three mutations including sense and antisense CpG alterations and identification of a deletional hot-spot in the alpha-galactosidase A gene. Hum Mol Genet 3:1795\u20131799","journal-title":"Hum Mol Genet"},{"key":"316_CR16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF03401671","volume":"3","author":"CM Eng","year":"1997","unstructured":"Eng CM, Ashley GA, Burgert TS, Enriquez AL, D\u2019Souza M, Desnick RJ (1997) Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes. Mol Med 3:174\u2013182","journal-title":"Mol Med"},{"key":"316_CR17","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1086\/318809","volume":"68","author":"CM Eng","year":"2001","unstructured":"Eng CM, Banikazemi M, Gordon RE, Goldman M, Phelps R, Kim L, Gass A, Winston J, Dikman S, Fallon JT, Grodie S, Stacy CB, Mehta D, Parsons R, Norton K, O\u2019Callaghan M, Desnick RJ (2001a) A phase 1\/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance, and safety studies. Am J Hum Genet 68:711\u2013722","journal-title":"Am J Hum Genet"},{"key":"316_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ (2001b) Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry\u2019s disease. N Engl J Med 345:9\u201316","journal-title":"N Engl J Med"},{"key":"316_CR19","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1111\/j.1742-4658.2007.06041.x","volume":"274","author":"J-Q Fan","year":"2007","unstructured":"Fan J-Q, Ishii S (2007) Active-site specific chaperone for Fabry disease; Yin and Yang of enzyme inhibitors. FEBS J 274:4962\u20134971","journal-title":"FEBS J"},{"key":"316_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1056\/NEJM200107053450104","volume":"345","author":"A Frustaci","year":"2001","unstructured":"Frustaci A, Chimenti C, Ricci R, Natale L, Russo MA, Pieroni M, Eng CM, Desnick RJ (2001) Improvement in cardiac function in the cardiac variant of Fabry\u2019s disease with galactose-infusion therapy. N Engl J Med 345:25\u201332","journal-title":"N Engl J Med"},{"key":"316_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","volume":"337","author":"SC Garman","year":"2004","unstructured":"Garman SC, Garboczi DN (2004) The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol 337:319\u2013335","journal-title":"J Mol Biol"},{"key":"316_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1651-2227.2007.00198.x","volume":"96","author":"SC Garman","year":"2007","unstructured":"Garman SC (2007) Structure-function relationships in alpha-galactosidase A. Acta Paediatr Suppl 96:6\u201316","journal-title":"Acta Paediatr Suppl"},{"key":"316_CR23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s004390050292","volume":"98","author":"D Germain","year":"1996","unstructured":"Germain D, Biasotto M, Tosi M, Meo T, Kahn A, Poenaru L (1996) Fluorescence-assisted mismatch analysis (FAMA) for exhaustive screening of the alpha-galactosidase A gene and detection of carriers in Fabry disease. Hum Genet 98:719\u2013726","journal-title":"Hum Genet"},{"key":"316_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/humu.41","volume":"17","author":"DP Germain","year":"2001","unstructured":"Germain DP, Salard D, Fellmann F, Azibi K, Caillaud C, Bernard MC, Poenaru L (2001) Identification of a novel de novo mutation (G373D) in the alpha-galactosidase A gene (GLA) in a patient affected with Fabry disease. Hum Mutat 17:353","journal-title":"Hum Mutat"},{"key":"316_CR25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF03402156","volume":"8","author":"DP Germain","year":"2002","unstructured":"Germain DP, Shabbeer J, Cotigny S, Desnick RJ (2002) Fabry disease: twenty novel alpha-galactosidase A mutations and genotype-phenotype correlations in classical and variant phenotypes. Mol Med 8:306\u2013312","journal-title":"Mol Med"},{"key":"316_CR26","doi-asserted-by":"publisher","first-page":"S288","DOI":"10.1002\/humu.1380110190","volume":"1","author":"N Guffon","year":"1998","unstructured":"Guffon N, Froissart R, Chevalier-Porst F, Maire I (1998) Mutation analysis in 11 French patients with Fabry disease. Hum Mutat Suppl 1:S288\u2013S290","journal-title":"Hum Mutat Suppl"},{"key":"316_CR27","first-page":"126","volume":"109","author":"MI Iga","year":"2001","unstructured":"Iga MI, Okayama A, Matsuyama M, Sasaki T, Murai K, Hashida S, Morishita K, Tsubouchi H (2001) Human gene mutations. Hum Genet 109:126","journal-title":"Hum Genet"},{"key":"316_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF00207037","volume":"89","author":"S Ishii","year":"1992","unstructured":"Ishii S, Sakuraba H, Suzuki Y (1992) Point mutations in the upstream region of the alpha-galactosidase A gene exon 6 in an atypical variant of Fabry disease. Hum Genet 89:29\u201332","journal-title":"Hum Genet"},{"key":"316_CR29","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1006\/bbrc.1993.2659","volume":"197","author":"S Ishii","year":"1993","unstructured":"Ishii S, Kase R, Sakuraba H, Suzuki Y (1993) Characterization of mutant alpha-galactosidase gene product for the late-onset cardiac form of Fabry disease. Biochem Biophys Res Commun 197:1585\u20131589","journal-title":"Biochem Biophys Res Commun"},{"key":"316_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1042\/BJ20070479","volume":"406","author":"S Ishii","year":"2007","unstructured":"Ishii S, Chang HH, Kawasaki K, Yasuda K, Wu HL, Garman SC, Fan JQ (2007) Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin. Biochem J 406:285\u2013295","journal-title":"Biochem J"},{"key":"316_CR31","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1107\/S0567739476001873","volume":"32","author":"W Kabsch","year":"1976","unstructured":"Kabsch W (1976) A solution for the best rotation to relate two sets of vectors. Acta Crystallogr A 32:827","journal-title":"Acta Crystallogr A"},{"key":"316_CR32","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1107\/S0567739478001680","volume":"34","author":"W Kabsch","year":"1978","unstructured":"Kabsch W (1978) A discussion of the solution for the best rotation to relate two sets of vectors. Acta Crystallogr A 34:922\u2013923","journal-title":"Acta Crystallogr A"},{"key":"316_CR33","first-page":"227","volume":"1501","author":"R Kase","year":"2000","unstructured":"Kase R, Bierfreund U, Klein A, Kolter T, Utsumi K, Itoh K, Sandhoff K, Sakuraba H (2000) Characterization of two alpha-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease. Biochem Biophys Res Commun 1501:227\u2013235","journal-title":"Biochem Biophys Res Commun"},{"key":"316_CR34","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1046\/j.1365-2133.2002.04902.x","volume":"147","author":"K Kimura","year":"2002","unstructured":"Kimura K, Sato-Matsumura KC, Nakamura H, Onodera Y, Morita K, Enami N, Shougase T, Ohsaki T, Kato M, Takahashi T, Yamaguchi Y, Shimizu H (2002) A novel A97P amino acid substitution in alpha-galactosidase A leads to a classical Fabry disease with cardiac manifestations. Br J Dermatol 147:545\u2013548","journal-title":"Br J Dermatol"},{"key":"316_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0014-5793(90)80046-L","volume":"259","author":"T Koide","year":"1990","unstructured":"Koide T, Ishiura M, Iwai K, Inoue M, Kaneda Y, Okada Y, Uchida T (1990) A case of Fabry\u2019s disease in a patient with no alpha-galactosidase A activity caused by a single amino acid substitution of Pro-40 by Ser. FEBS Lett 259:353\u2013356","journal-title":"FEBS Lett"},{"key":"316_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1063\/1.474409","volume":"107","author":"MJ Kong","year":"1997","unstructured":"Kong MJ, Ponder JW (1997) Reaction field methods for off-center multipoles. J Chem Phys 107:481\u2013492","journal-title":"J Chem Phys"},{"key":"316_CR37","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","volume":"15","author":"P Kotanko","year":"2004","unstructured":"Kotanko P, Kramar R, Devrnja D, Paschke E, Voigtl\u00e4nder T, Auinger M, Pagliardini S, Spada M, Demmelbauer K, Lorenz M, Hauser AC, Kofler HJ, Lhotta K, Neyer U, Pronai W, Wallner M, Wieser C, Wiesholzer M, Zodl H, F\u00f6dinger M, Sunder-Plassmann G (2004) Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol 15:1323\u20131329","journal-title":"J Am Soc Nephrol"},{"key":"316_CR38","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/jcc.540120314","volume":"12","author":"CE Kundrot","year":"1991","unstructured":"Kundrot CE, Ponder JW, Richards FM (1991) Algorithms for calculating excluded volume and its derivative as a function of molecular conformation and their use in energy minimization. J Comput Chem 12:402\u2013409","journal-title":"J Comput Chem"},{"key":"316_CR39","first-page":"469","volume":"109","author":"L Lai","year":"2001","unstructured":"Lai L, O\u2019Meara M, Lien YH (2001) Human gene mutations. Hum Genet 109:469","journal-title":"Hum Genet"},{"key":"316_CR40","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1034\/j.1399-0004.2000.580311.x","volume":"58","author":"JK Lee","year":"2000","unstructured":"Lee JK, Kim GH, Kim JS, Kim KK, Lee MC, Yoo HW (2000) Identification of four novel mutations in five unrelated Korean families with Fabry disease. Clin Genet 58:228\u2013233","journal-title":"Clin Genet"},{"key":"316_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00439-005-1300-5","volume":"117","author":"F Matsuzawa","year":"2005","unstructured":"Matsuzawa F, Aikawa S, Doi H, Okumiya T, Sakuraba H (2005) Fabry disease: correlation between structural changes in alpha-galactosidase, and clinical and biochemical phenotype. Hum Genet 117:317\u2013328","journal-title":"Hum Genet"},{"key":"316_CR42","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1006\/jmbi.1994.1334","volume":"238","author":"IK McDonald","year":"1994","unstructured":"McDonald IK, Thornton JM (1994) Satisfying hydrogen bonding potential in proteins. J Mol Biol 238:777\u2013793","journal-title":"J Mol Biol"},{"key":"316_CR43","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1002\/humu.1380110147","volume":"1","author":"T Miyazaki","year":"1998","unstructured":"Miyazaki T, Kajita M, Ohmori S, Mizutani N, Niwa T, Murata Y, Seo H (1998) A novel mutation (E358K) in the alpha-galactosidase A gene detected in a Japanese family with Fabry disease. Hum Mutat Suppl 1:S139\u2013S140","journal-title":"Hum Mutat Suppl"},{"key":"316_CR44","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1136\/jmg.40.8.e103","volume":"40","author":"A Morrone","year":"2003","unstructured":"Morrone A, Cavicchi C, Bardelli T, Antuzzi D, Parini R, Di Rocco M, Feriozzi S, Gabrielli O, Barone R, Pistone G, Spisni C, Ricci R, Zammarchi E (2003) Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers. J Med Genet 40:e103","journal-title":"J Med Genet"},{"key":"316_CR45","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, Yoshida A, Kuriyama M, Hayashibe H, Sakuraba H et al (1995) An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy. N Engl J Med 333:288\u201393","journal-title":"N Engl J Med"},{"key":"316_CR46","doi-asserted-by":"crossref","unstructured":"Ohno K, Saito S, Sugawara K, Sakuraba H (2008) Structural consequences of amino acid substitutions causing Tay-Sachs disease. Mol Genet Metab (in press)","DOI":"10.1016\/j.ymgme.2008.04.006"},{"key":"316_CR47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/BF00223869","volume":"95","author":"T Okumiya","year":"1995","unstructured":"Okumiya T, Ishii S, Kase R, Kamei S, Sakuraba H, Suzuki Y (1995a) Alpha-galactosidase gene mutations in Fabry disease: heterogeneous expressions of mutant enzyme protein. Hum Genet 95:557\u2013561","journal-title":"Hum Genet"},{"key":"316_CR48","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1006\/bbrc.1995.2416","volume":"214","author":"T Okumiya","year":"1995","unstructured":"Okumiya T, Ishii S, Takenaka T, Kase R, Kamei S, Sakuraba H, Suzuki Y (1995b) Galactose stabilizes various missense mutants of alpha-galactosidase in Fabry disease. Biochem Biophys Res Commun 214:1219\u20131224","journal-title":"Biochem Biophys Res Commun"},{"key":"316_CR49","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1002\/humu.1380110169","volume":"1","author":"T Okumiya","year":"1998","unstructured":"Okumiya T, Kawamura O, Itoh K, Kase R, Ishii S, Kamei S, Sakuraba H (1998) Novel missense mutation (M72\u00a0V) of alpha-galactosidase gene and its expression product in an atypical Fabry hemizygote. Hum Mutat Suppl 1:S213\u2013S216","journal-title":"Hum Mutat Suppl"},{"key":"316_CR50","doi-asserted-by":"publisher","first-page":"9725","DOI":"10.1021\/jp982255t","volume":"102","author":"RV Pappu","year":"1998","unstructured":"Pappu RV, Hart RW, Ponder JW (1998) Analysis and application of potential energy smoothing for global optimization. J Phy Chem B 102:9725\u20139742","journal-title":"J Phy Chem B"},{"key":"316_CR51","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/hmg\/3.3.503","volume":"3","author":"JK Ploos van Amstel","year":"1994","unstructured":"Ploos van Amstel JK, Jansen RP, de Jong JG, Hamel BC, Wevers RA (1994) Six novel mutations in the alpha-galactosidase A gene in families with Fabry disease. Hum Mol Genet 3:503\u2013505","journal-title":"Hum Mol Genet"},{"key":"316_CR52","doi-asserted-by":"publisher","first-page":"5933","DOI":"10.1021\/jp027815+","volume":"107","author":"P Ren","year":"2003","unstructured":"Ren P, Ponder JW (2003) Polarizable atomic multipole water model for molecular mechanics simulation. J Phy Chem B 107:5933\u20135947","journal-title":"J Phy Chem B"},{"key":"316_CR53","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/humu.9172","volume":"2","author":"A Rodr\u00edguez-Mar\u00ed","year":"2003","unstructured":"Rodr\u00edguez-Mar\u00ed A, Coll MJ, Chab\u00e1s A (2003) Molecular analysis in Fabry disease in Spain: fifteen novel GLA mutations and identification of a homozygous female. Hum Mutat 2:258","journal-title":"Hum Mutat"},{"key":"316_CR54","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","volume":"105","author":"B Sachdev","year":"2002","unstructured":"Sachdev B, Takenaka T, Teraguchi H, Tei C, Lee P, McKenna WJ, Elliott PM (2002) Prevalence of Anderson- Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 105:1407\u20131411","journal-title":"Circulation"},{"key":"316_CR55","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ymgme.2007.11.017","volume":"93","author":"S Saito","year":"2008","unstructured":"Saito S, Ohno K, Sugawara K, Sakuraba H (2008) Structural and clinical implications of amino acid substitutions in N-acetylgalactosamine-4-sulfatase: Insight into mucopolysaccharidosis type VI. Mol Genet Metab 93:419\u2013425","journal-title":"Mol Genet Metab"},{"key":"316_CR56","first-page":"784","volume":"47","author":"H Sakuraba","year":"1990","unstructured":"Sakuraba H, Oshima A, Fukuhara Y, Shimmoto M, Nagao Y, Bishop DF, Desnick RJ, Suzuki Y (1990) Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease. Am J Hum Genet 47:784\u2013789","journal-title":"Am J Hum Genet"},{"key":"316_CR57","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s100380200020","volume":"47","author":"H Sakuraba","year":"2000","unstructured":"Sakuraba H, Matsuzawa F, Aikawa S, Doi H, Kotani M, Lin H, Ohno K, Tanaka A, Yamada H, Uyama E (2000) Molecular and structural studies of the GM2 gangliosidosis O variant. J Hum Genet 47:176\u2013183","journal-title":"J Hum Genet"},{"key":"316_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10038-003-0098-z","volume":"49","author":"H Sakuraba","year":"2004","unstructured":"Sakuraba H, Matsuzawa F, Aikawa S, Doi H, Kotani M, Nakada H, Fukushige T, Kanzaki T (2004) Structural and immunocytochemical studies on alpha-N-acetylgalactosaminidase deficiency (Schindler\/Kanzaki disease). J Hum Genet 49:1\u20138","journal-title":"J Hum Genet"},{"key":"316_CR59","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/humu.9327","volume":"25","author":"E Sch\u00e4fer","year":"2005","unstructured":"Sch\u00e4fer E, Baron K, Widmer U, Deegan P, Neumann HP, Sunder-Plassmann G, Johansson JO, Whybra C, Ries M, Pastores GM, Mehta A, Beck M, Gal A (2005) Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease. Hum Mutat 25:412","journal-title":"Hum Mutat"},{"key":"316_CR60","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1073\/pnas.97.1.365","volume":"97","author":"R Schiffmann","year":"2000","unstructured":"Schiffmann R, Murray GJ, Treco D, Daniel P, Sellos-Moura M, Myers M, Quirk JM, Zirzow GC, Borowski M, Loveday K, Anderson T, Gillespie F, Oliver KL, Jeffries NO, Doo E, Liang TJ, Kreps C, Gunter K, Frei K, Crutchfield K, Selden RF, Brady RO (2000) Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci USA 97:365\u2013370","journal-title":"Proc Natl Acad Sci USA"},{"key":"316_CR61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1096-7192(02)00012-4","volume":"76","author":"J Shabbeer","year":"2002","unstructured":"Shabbeer J, Yasuda M, Luca E, Desnick RJ (2002) Fabry disease: 45 novel mutations in the alpha-galactosidase A gene causing the classical phenotype. Mol Genet Metab 76:23\u201330","journal-title":"Mol Genet Metab"},{"key":"316_CR62","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/humu.20144","volume":"25","author":"J Shabbeer","year":"2005","unstructured":"Shabbeer J, Robinson M, Desnick RJ (2005) Detection of alpha-galactosidase A mutations causing Fabry disease by denaturing high performance liquid chromatography. Hum Mutat 25:299\u2013305","journal-title":"Hum Mutat"},{"key":"316_CR63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1479-7364-2-5-297","volume":"2","author":"J Shabbeer","year":"2006","unstructured":"Shabbeer J, Yasuda M, Benson SD, Desnick RJ (2006) Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations. Hum Genomics 2:297\u2013309","journal-title":"Hum Genomics"},{"key":"316_CR64","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H, Ponzon A, Desnick RJ (2006) High incidence of later-onset Fabry disease revealed by newborn screening. Am J Hum Genet 79:31\u201340","journal-title":"Am J Hum Genet"},{"key":"316_CR65","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10038-008-0272-4","volume":"53","author":"K Sugawara","year":"2008","unstructured":"Sugawara K, Saito S, Ohno K, Okuyama T, Sakuraba H (2008) Structural study on mutant alpha-L-iduronidases: insight into mucopolysaccharidosis type I. J Hum Genet 53:467\u2013474","journal-title":"J Hum Genet"},{"key":"316_CR66","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0387-7604(96)00486-X","volume":"19","author":"T Takata","year":"1997","unstructured":"Takata T, Okumiya T, Hayashibe H, Shimmoto M, Kase R, Itoh K, Utsumi K, Kamei S, Sakuraba H (1997) Screening and detection of gene mutations in Japanese patients with Fabry disease by non-radioactive single-stranded conformation polymorphism analysis. Brain Dev 19:111\u2013116","journal-title":"Brain Dev"},{"key":"316_CR67","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/BF03401993","volume":"5","author":"AK Topaloglu","year":"1999","unstructured":"Topaloglu AK, Ashley GA, Tong B, Shabbeer J, Astrin KH, Eng CM, Desnick RJ (1999) Twenty novel mutations in the alpha-galactosidase A gene causing Fabry disease. Mol Med 5:806\u2013811","journal-title":"Mol Med"},{"key":"316_CR68","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/sj.ejhg.5201184","volume":"12","author":"F Verovnik","year":"2004","unstructured":"Verovnik F, Benko D, Vujkovac B, Linthorst GE (2004) Remarkable variability in renal disease in a large Slovenian family with Fabry disease. Eur J Hum Genet 12:678\u2013681","journal-title":"Eur J Hum Genet"},{"key":"316_CR69","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJM199102073240607","volume":"324","author":"W Scheidt von","year":"1991","unstructured":"von Scheidt W, Eng CM, Fitzmaurice TF, Erdmann E, H\u00fcbner G, Olsen EG, Christomanou H, Kandolf R, Bishop DF, Desnick RJ (1991) An atypical variant of Fabry\u2019s disease with manifestations confined to the myocardium. N Engl J Med 324:395\u2013399","journal-title":"N Engl J Med"},{"key":"316_CR70","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1021\/ja00315a051","volume":"106","author":"SJ Weiner","year":"1984","unstructured":"Weiner SJ, Kallman PA, Case DA, Singh UC, Ghio C, Alagona G, Profeta S, Weiner P (1984) A new force field for molecular mechanical simulation of nucleic acids and proteins. J Am Chem Soc 106:765\u2013784","journal-title":"J Am Chem Soc"},{"key":"316_CR71","doi-asserted-by":"publisher","first-page":"C1076","DOI":"10.1152\/ajpcell.00426.2005","volume":"290","author":"GH-F Yam","year":"2006","unstructured":"Yam GH-F, Bosshard N, Zuber C, Steinmann B, Roth J (2006) Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants. Am J Physiol Cell Physiol 290:C1076\u2013C1082","journal-title":"Am J Physiol Cell Physiol"},{"key":"316_CR72","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1034\/j.1399-0004.2003.00050.x","volume":"63","author":"CC Yang","year":"2003","unstructured":"Yang CC, Lai LW, Whitehair O, Hwu WL, Chiang SC, Lien YH (2003) Two novel mutations in the alpha-galactosidase A gene in Chinese patients with Fabry disease. Clin Genet 63:205\u2013209","journal-title":"Clin Genet"},{"key":"316_CR73","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/humu.10275","volume":"22","author":"M Yasuda","year":"2003","unstructured":"Yasuda M, Shabbeer J, Benson SD, Maire I, Burnett RM, Desnick RJ (2003) Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele. Hum Mutat 22:486\u2013492","journal-title":"Hum Mutat"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/jhg2008102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg2008102","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/jhg2008102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T19:37:22Z","timestamp":1638387442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhg2008102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,17]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["316"],"URL":"https:\/\/doi.org\/10.1007\/s10038-008-0316-9","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,17]]}}}